Immunotherapy in small bowel adenocarcinoma: a potential role?

被引:2
|
作者
Vitiello, Francesco [1 ]
Cereda, Stefano [1 ]
Foti, Silvia [1 ]
Liscia, Nicole [1 ]
Mazza, Elena [1 ]
Ronzoni, Monica [1 ]
Cascinu, Stefano [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Med Oncol, Comprehens Canc Ctr, Osped San Raffaele, Milan, Italy
关键词
Small bowel cancer; metastatic cancer; predictive markers; PDL-1; MSI; TMB; duodenal cancer; jejunal cancer; ileum tumor; CANCER;
D O I
10.1080/25785826.2023.2220938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy has demonstrated to be a valid therapeutic option for many solid tumors. We reviewed the data published in literature to understand the impact of immunotherapy in this cancer.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] Primary small bowel adenocarcinoma
    Ruiz-Tovar, Jaime
    Martinez-Molina, Enrique
    Morales, Vicente
    Sanjuanbenito, Alfonso
    CIRUGIA ESPANOLA, 2009, 85 (06): : 354 - 359
  • [22] Primary adenocarcinoma of the small bowel
    Ruiz-Tovar, J.
    Morales, V
    Martinez-Molina, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 61 - 61
  • [23] SMALL-BOWEL ADENOCARCINOMA
    MICHELASSI, F
    COVARELLI, P
    HART, J
    FICHERA, A
    BLOCK, GE
    GASTROENTEROLOGY, 1993, 104 (04) : A429 - A429
  • [24] Management of small bowel adenocarcinoma
    Kummar, S
    Ciesielski, TE
    Fogarasi, MC
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 1364 - 1369
  • [25] Small bowel adenocarcinoma: An overview
    Khosla, Divya
    Dey, Treshita
    Madan, Renu
    Gupta, Rahul
    Goyal, Shikha
    Kumar, Narendra
    Kapoor, Rakesh
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (02) : 413 - 422
  • [26] The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease
    Potter, DD
    Murray, JA
    Donohue, JH
    Burgart, LJ
    Nagorney, DM
    van Heerden, JA
    Plevak, MF
    Zinsmeister, AR
    Thibodeau, SN
    CANCER RESEARCH, 2004, 64 (19) : 7073 - 7077
  • [27] A potential association between exposure to hepatitis B virus and small bowel adenocarcinoma
    DeFilippis, Ersilia M.
    Mehta, Mamta
    Ludwig, Emmy
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (03) : 495 - 498
  • [28] ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
    Laforest, Anais
    Aparicio, Thomas
    Zaanan, Aziz
    Silva, Fabio Pittella
    Didelot, Audrey
    Desbeaux, Aurelien
    Le Corre, Delphine
    Benhaim, Leonor
    Pallier, Karine
    Aust, Daniela Ellen
    Pistorius, Steffen
    Blons, Helene
    Svrcek, Magali
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [29] ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
    Laforest, Anais
    Aparicio, Thomas
    Zaanan, Aziz
    Silva, Fabio Pittella
    Didelot, Audrey
    Desbeaux, Aurelien
    Le Corre, Delphine
    Benhaim, Leonor
    Pallier, Karine
    Aust, Daniela
    Pistorius, Steffen
    Blons, Helene
    Svrcek, Magali
    Laurent-Puig, Pierre
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (10) : 1740 - 1746
  • [30] Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo
    Palascak-Juif, V
    Bouvier, AM
    Cosnes, J
    Flourié, B
    Bouché, O
    Cadiot, G
    Lémann, M
    Bonaz, B
    Denet, C
    Marteau, P
    Gambiez, L
    Beaugerie, L
    Faivre, J
    Carbonnel, F
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (09) : 828 - 832